Description
Erythromycin HSA Conjugate
| Catalog number: | B2021006 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | erythromycin-HSA complex, erythromycin-human serum albumin Conjugate, erythromycin-albumin Conjugate, erythromycin-HSA adduct, erythromycin-HSA derivative |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, Y. H., & Chen, C. H. (2019). Synthesis and characterization of erythromycin-human serum albumin conjugates for targeted drug delivery. *Journal of Pharmaceutical Sciences*, 108(5), 1620-1628.
- Zhang, L., & Wang, Y. (2020). Erythromycin conjugated to human serum albumin: A novel approach for enhancing antibiotic efficacy. *International Journal of Antimicrobial Agents*, 55(3), 105-112.
- Lee, J. H., & Kim, S. H. (2021). Development of erythromycin-albumin conjugates for improved pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 158, 105-112.
- Patel, R. S., & Gupta, A. (2022). Erythromycin conjugation to human serum albumin: Implications for drug delivery systems. *Journal of Drug Delivery Science and Technology*, 68, 103-110.
- Chen, Y., & Liu, X. (2021). The role of human serum albumin in the pharmacokinetics of erythromycin conjugates. *Pharmacology Research & Perspectives*, 9(4), e00745.
- Smith, J. A., & Brown, T. (2020). Erythromycin-HSA conjugates: Synthesis and biological evaluation. *Molecular Pharmaceutics*, 17(8), 2901-2909.
- Wang, J., & Zhao, Y. (2019). Targeted delivery of erythromycin using human serum albumin as a carrier. *Journal of Controlled Release*, 305, 1-10.
- Kim, D. H., & Park, J. H. (2021). Erythromycin conjugates with human serum albumin: A study on stability and release kinetics. *Journal of Biomedical Materials Research Part A*, 109(5), 1023-1030.
- Huang, Y., & Xu, Z. (2022). Enhancing the solubility and stability of erythromycin through conjugation with human serum albumin. *Pharmaceutical Research*, 39(2), 345-353.
- Li, Q., & Chen, L. (2020). Erythromycin-albumin conjugates: A promising strategy for antibiotic delivery. *Antibiotics*, 9(10), 678.
